Cancer Care Northwest-North

Spokane, Washington 99218

0 studies enrolling now · 8 studies all time

What they study most

Breast Cancer, Hormone Refractory Prostate Cancer, Lung Cancer, Metastatic Breast Cancer, Non-Hodgkin's Lymphoma, Non-small Cell Lung Cancer, Prostate Cancer

Studies at this site

• Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer — Status unconfirmed
• Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer — Completed
• Study Evaluating The Effects Of Neratinib After Adjuvant Trastuzumab In Women With Early Stage Breast Cancer — Completed
• Doxil & Carboplatin Plus HER2+ in Metastatic Breast Cancer — Completed
• A Study of Erlotinib (Tarceva) After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma (NSCLC) Patients Who Have Epidermal Growth Factor Receptor (EGFR) Positive Tumors — Completed
• Vaccine Therapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer — Status unconfirmed
• Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen — Completed
• Trial of Outpatient Immunotherapy With Rituximab and Aldesleukin (IL-2) vs. Rituximab Alone for Non-Hodgkin's Lymphoma — Stopped early